Zealand Pharma

📍 Søborg (Copenhagen), Denmark🗓 Founded 1998👥 283 employees💰 Last funded Apr 2019
Biotechnology Research🌐 zealandpharma.com
Website LinkedIn
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn or Twitter @ZealandPharma.
5
Total investors
0
Early stage
0
Mid stage
2
Late stage
1998
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
2
Denmark
2
United States
1
Investor activity2006–2019 · investors recorded per year
2006120071200912018120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Zealand Pharma?
Zealand Pharma has 5 investors on record on gritt.io and 2 late-stage investors.
When did Zealand Pharma last raise funding?
The most recent investment in Zealand Pharma recorded on gritt.io was in April 2019.
When was Zealand Pharma founded?
Zealand Pharma was founded in 1998.
What industry is Zealand Pharma in?
Zealand Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zealand Pharma based?
Zealand Pharma is headquartered in Søborg (Copenhagen), Denmark.